Work

Measurable residual disease is not a universally reliable surrogate for progression-free survival in clinical trials of new chronic lymphocytic leukemia therapies

Year: 2026

Type: article

Study designs: Systematic Review, Meta-Analysis

Source: Leukemia

DOI: 10.1038/s41375-026-02970-x

Authors: Yun Wang, Chunhua Li, Robert Peter Gale, Qi Liang, Neil E. Kay, Qianqian Huang, Yiling Song, Weida Wang, Yang Liang

Institutions: Sun Yat-sen University, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Imperial College London, Mayo Clinic

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Natural Science Foundation of China, Chinese Society of Clinical Oncology, Basic and Applied Basic Research Foundation of Guangdong Province

Awards: G1019769955, G665474047

OpenAlex ID: W7159648984

FWCI: 15.06

Cites:

Cited by: 4

Related to: